Clarus Therapeutics Hldgs Inc (CRXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRXT | SNOA | CANF | ||
| Company | Clarus Therapeutics Hldgs Inc | Sonoma Pharmaceuticals Inc | Can-Fite Biopharma Ltd ADR | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NYSE Arca | ||
| Open | 0.0650 | 2.26 | 3.03 | ||
| High | 0.0749 | 2.54 | 3.21 | ||
| Low | 0.0475 | 2.21 | 2.96 | ||
| Latest | 0.0475 | 2.43 | 3.09 | ||
| Change | -0.0215 | +0.30 | -0.01 | ||
| % Change | -31.16% | +14.08% | -0.32% | ||
| Volume | 2,737,100 | 89,700 | 15,200 | ||
| 20-Day Average Volume | 4,348,840 | 37,635 | 122,930 | ||
| Previous Close | 0.0690 | 2.13 | 3.10 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.2088 | 2.38 | 3.55 | ||
| 20-Day Raw Stochastic | 0.00% | 55.84% | 5.83% | ||
| 20-Day Relative Strength | 26.48 | 44.79 | 38.06 | ||
| Weighted Alpha | -96.72 | -52.50 | -87.52 | ||
| Today's Opinion | 100% Sell | 88% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -69.75% since 08/29/22 | +6.58% since 03/25/26 | -4.33% since 03/25/26 | ||
| Low | 0.0475 on 09/06/22 | 2.00 on 03/31/26 | 2.95 on 03/31/26 | ||
| High | 0.1400 on 08/30/22 | 2.54 on 04/01/26 | 3.39 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | -84.34% since 08/05/22 | -16.21% since 02/27/26 | -34.95% since 02/27/26 | ||
| Low | 0.0475 on 09/06/22 | 2.00 on 03/31/26 | 2.95 on 03/31/26 | ||
| High | 0.3489 on 08/15/22 | 3.06 on 03/02/26 | 10.40 on 03/04/26 | ||
| 3-Month | |||||
| %Chg | -90.08% since 06/06/22 | -33.24% since 12/31/25 | -22.75% since 12/31/25 | ||
| Low | 0.0475 on 09/06/22 | 2.00 on 03/31/26 | 2.95 on 03/31/26 | ||
| High | 0.4659 on 06/07/22 | 3.89 on 01/05/26 | 10.40 on 03/04/26 | ||
| 6-Month | |||||
| %Chg | -93.21% since 03/04/22 | -37.05% since 10/01/25 | -74.81% since 10/01/25 | ||
| Low | 0.0475 on 09/06/22 | 2.00 on 03/31/26 | 2.95 on 03/31/26 | ||
| High | 3.9400 on 04/20/22 | 4.60 on 10/06/25 | 12.73 on 10/06/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,471 | 3,686 | 2,030 | ||
| Shares Outstanding, K | 52,021 | 1,731 | 655 | ||
| Annual Sales | 13,960,000 | 14,290,000 | 410,000 | ||
| Annual Net Income | -40,620,000 | -3,460,000 | -9,830,000 | ||
| Last Quarter Sales | 4,050,000 | 4,350,000 | 160,000 | ||
| Last Quarter Net Income | -10,690,000 | -820,000 | -1,650,000 | ||
| 60-Month Beta | 1.96 | 1.66 | 1.01 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 08/18/22 | -0.35 on 02/10/26 | N/A | ||
| Latest Earnings Date | 11/17/22 | 06/16/26 | 04/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||